• Its proprietary progressive polymer know-how reduces bacterial bioburden with out triggering antimicrobial resistance, one of many prime international public well being threats
• The Advanced Wound Dressing (AWD) market is valued at 4.5 billion USD and is witnessing growing demand and technological developments
• The firm is trying to increase growth and business collaborations with trade leaders

BERN Switzerland, Feb. 11, 2024 /PRNewswire/ — Polaroid Therapeutics, a Swiss-based biotech start-up, is growing superior antimicrobial therapies to reinforce affected person outcomes worldwide. Today, the corporate is happy to announce the achievement of great pre-clinical milestones in growing its progressive medical gadget.

Polaroid Therapeutics is making a pioneering antimicrobial polymer know-how. These secure and extremely potent polymers disrupt bacterial cells in a singular mechanism of motion. They have an instantaneous and long-lasting exercise with out inflicting antimicrobial resistance (AMR).

Today, the misuse and overuse of antimicrobials are the principle drivers of AMR.  When antibiotics and antimicrobial brokers are used excessively or inappropriately, micro organism, viruses, fungi, and parasites can adapt to them, making these remedies much less efficient over time. According to the World Health Organization, AMR is without doubt one of the prime international public well being and growth threats. It is estimated that bacterial AMR was immediately liable for 1.27 million international deaths in 2019 and contributed to 4.95 million deaths. ^[1]

Originating from Polaroid, the model that pioneered the chemistry behind analog prompt pictures, Polaroid Therapeutics’ mission is to create a extra human and significant world by cutting-edge know-how and analysis. The firm is trying to increase collaborations with trade leaders in superior wound care, develop superior healthcare merchandise, and champion a patient-centric care system that units new requirements in medical remedy and affected person expertise.

Globally, 1-2% of the inhabitants suffers from persistent wound issues every year.^[2] This variety of affected sufferers will improve as international populations proceed to age. As we acknowledge the rising want for persistent wound administration, there’s a vital alternative to advance healthcare practices. By prioritizing efficient remedy methods for persistent wounds, we are able to improve affected person care and optimize healthcare sources. This proactive method isn’t just about enhancing affected person outcomes; it additionally represents a step in direction of a extra environment friendly and sustainable healthcare system globally.

The international Advanced Wound Dressing (AWD) market was valued at 4.5 billion (USD) in 2022 and is projected to increase at a compound annual development price (CAGR) of 4.5% from 2023 to 2030, with antimicrobial merchandise representing 1 / 4 of the entire AWD market. The market is witnessing growing demand pushed by technological developments, surgical procedures, and the rising prevalence of persistent wounds. This presents a chance for Polaroid Therapeutics and its companions to capitalize on superior product growth and an unwavering concentrate on enhancing affected person outcomes. As the market continues to evolve, alternatives for innovation and collaboration are ripe, positioning the trade – and thought leaders like Polaroid Therapeutics – for sustained development and development.

Ran Frenkel, CEO and Co-Founder of Polaroid Therapeutics mentioned, “We are operating in an incredibly complex space. Globally, the medical needs remain unmet, meaning patients are at risk of severe long-term complications. At Polaroid Therapeutics, we aim to change this. Our technologies will benefit both patients and the wider care ecosystem and, in turn, reposition chronic wound care as not simply the management of, but effective solution. People are suffering and we believe we can alleviate this on a global scale.”

About Polaroid Therapeutics:

Polaroid Therapeutics is a Swiss-based biotech start-up within the growth of progressive antimicrobial know-how. Incubated and spun off by Polaroid, the model that pioneered the chemistry behind analogue prompt pictures. Polaroid Therapeutics’ mission is to carry to life one of the best of Polaroid’s imaginative and prescient of making a extra human and significant world by cutting-edge know-how and analysis.

Founded in 2022, Polaroid Therapeutics is growing antimicrobial therapies based mostly on proprietary antibacterial know-how to stop and inhibit infections in a number of indications, resembling acute and persistent wounds. This distinctive know-how is a breakthrough resolution that doesn’t create antimicrobial resistance (AMR) – considered probably the most distinguished international menace to well being.

Contact:

Abigail Carrigan
[email protected]

Photo – https://mma.prnewswire.com/media/2338334/Polaroid_Therapeutics__Core_Tech_Asset.jpg
Logo – https://mma.prnewswire.com/media/2338335/Polaroid_Theraphuetics_Logo.jpg

^[1] World Health Organisation
^[2] Lindholm, C. and Searle, R. (2016) ‘Wound administration for the twenty first century: combining effectiveness and effectivity,’ International Wound Journal, 13(S2), pp. 5–15. https://doi.org/10.1111/iwj.12623.
3 BioMedGPS© 2022 Global Advanced Wound Dressing www.smarttrak.com

SOURCE Polaroid Therapuetics’